KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $565.0 million.

  • Cme's Operating Expenses rose 85.68% to $565.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 billion, marking a year-over-year increase of 198.95%. This contributed to the annual value of $2.2 billion for FY2024, which is 258.49% up from last year.
  • Per Cme's latest filing, its Operating Expenses stood at $565.0 million for Q3 2025, which was up 85.68% from $562.7 million recorded in Q2 2025.
  • In the past 5 years, Cme's Operating Expenses ranged from a high of $578.2 million in Q4 2024 and a low of $487.5 million during Q1 2022
  • For the 5-year period, Cme's Operating Expenses averaged around $529.0 million, with its median value being $528.2 million (2021).
  • Its Operating Expenses has fluctuated over the past 5 years, first plummeted by 1163.67% in 2021, then soared by 828.72% in 2023.
  • Quarter analysis of 5 years shows Cme's Operating Expenses stood at $515.6 million in 2021, then increased by 4.64% to $539.5 million in 2022, then rose by 6.78% to $576.1 million in 2023, then grew by 0.36% to $578.2 million in 2024, then fell by 2.28% to $565.0 million in 2025.
  • Its Operating Expenses stands at $565.0 million for Q3 2025, versus $562.7 million for Q2 2025 and $534.3 million for Q1 2025.